When considering the value of medication adherence, we have typically spoken of improving this aspect of healthcare quality in the context of CMS Stars adherence measures; however, research has also illustrated savings in total cost of care through improved medication adherence. Discover how RxAnte's Value of Future Adherence software is providing plans another way to view their members' medication use.

As plans evaluate their pharmacy quality performance, it is important to consider what adjustments might be made to maintain the most effective outreach program to positively impact influence members’ medication use. This month, Luke Ellis, Manager of Client Operations at RxAnte, shares insight into how we develop the best medication adherence program for each health plan client.

This month, Josh Benner, Founder and CEO of RxAnte, talked with Jill Murphy of Pharmacy Focus, a Pharmacy Times health podcast, to discuss medication misuse and the future of pharmacy.

This month, we take a deeper dive into how technology is transforming the role of pharmacy. Sapna Patel, RPh, Director of Clinical Services at Mosaic Pharmacy Service, provides insight into how she has seen the traditional role of pharmacy evolve; what trends may impact the industry; and how the increasing use of technology in the field can empower the pharmacist to improve patient health.

On October 8th, CMS released its 2021 Star Ratings. RxAnte has analyzed performance both for the industry as a whole and within our book of business. Ahead of our more detailed industry analysis to be released in the coming week, we're sharing our 5 key takeaways at a glance.

CMS’s release of the 2021 Star Ratings cut points earlier this month reveals that—once again—RxAnte clients show improvement in adherence measures despite persistently rising cut points. For 2020, 90 percent of RxAnte-managed contracts are on track to improve adherence.